The Latest on Diet & Acne…And The Truth About Chlorophyll!
Diet & AcneSeveral media outlets have covered the TikTok trend of drinking chlorophyll for clearer skin. Is there any science behind drinking chlorophyll to treat acne? What are the most recent developments in the study of diet and acne? To answer these questions, I contacted dermatologist Rajani Katta, MD, volunteer clinical faculty at Baylor College of Medicine and McGovern Medical School at UT Health. …
Diet & Acne
From Port-Wine Stain Treatments to Bovine Colostrum, Telomeres, and Skin Aging
Port-Wine StainThe May issue of the Journal of Drugs in Dermatology features dermatology articles on topics ranging from treatment updates on Port-Wine stain to the protective effect that liposomal bovine colostrum exerts on skin aging using telomere length as an aging biomarker. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Authors analyze extrusion forces of various produ …
Port-Wine Stain
Tumor Mutations – Friday Pop Quiz 5/14
Tumor Mutations This tumor commonly results from mutations in p53. Which of the following is correct? A. It is the most common type of skin cancer in Caucasians B. Oral variants most commonly present on the dorsal tongue C. It is typically less aggressive in patients with CLL D. plant patients have a 10-fold increased risk of developing this tumor E. Tumors arising within scars/chronic ulcers h …
Tumor Mutations
Lichen Planopilaris and Frontal Fibrosing Alopecia: Treatment Algorithms
lichen planopilaris and frontal fibrosing alopeciaDr. Jerry Shapiro, or the “Lord of the Hair” (as described by ODAC conference co-chair Dr. Adam Friedman) provided us with an A to Z overview of frontal fibrosing alopecia (FFA) and lichen planopilaris (LPP) as well royalty-worthy pearls and treatment updates. Before we start, here are my favorite quotes from Dr. Shapiro, which also serve as a great summary of his wonderful lecture: “Fro …
lichen planopilaris and frontal fibrosing alopecia
Prescribing Isotretinoin for Transgender Patients
isotretinoin for transgender patientsCase Scenario A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections. He has not had any gender-affirming surgeries and reports being currently amenorrhoeic. He is curren …
isotretinoin for transgender patients